Microglia-targeting nanotherapeutics for neurodegenerative diseases

Advances in nanotechnology have enabled the design of nanotherapeutic platforms that could address the challenges of targeted delivery of active therapeutic agents to the central nervous system (CNS). While the majority of previous research studies on CNS nanotherapeutics have focused on neurons and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Nanxia, Francis, Nicola L., Calvelli, Hannah R., Moghe, Prabhas V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIP Publishing LLC 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481010/
https://www.ncbi.nlm.nih.gov/pubmed/32923843
http://dx.doi.org/10.1063/5.0013178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481010/
https://www.ncbi.nlm.nih.gov/pubmed/32923843
http://dx.doi.org/10.1063/5.0013178

Ejemplares similares